IL-10 fusion protein (Case Western/Copernicus)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIL-10 fusion protein (Case Western/Copernicus)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibodyBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionInterleukin 10 receptor agonists

TargetsInterleukin 10 receptor

Therapy Area/IndicationsInflammationAsthmaInflammatory Bowel Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCase Western Reserve University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCopernicus Therapeutics Case Western Reserve University

Active IndicationsN/A

Inactive IndicationsInflammationAsthmaInflammatory Bowel Diseases

Other Information

ATC CodeN/A